|
|
Article: Scimitar Equity Research, Inc. Maintains ``BUY'' Stock Ranking of Physiometrix, Inc.
- Article from:
- Business Wire
- Article date:
- May 6, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
BOSTON--(BUSINESS WIRE)--May 6, 2004
Scimitar Equity Research, Inc. (Scimitar) announced maintaining the "BUY" stock ranking of Physiometrix, Inc. (PHYX). The research review is entitled, "Maintain a Patient State. The Ultimate Yardstick is...Market Acceptance." The review is available on Scimitar's website: www.scimitarequity.com.
Scimitar Equity Research, Inc. provides Unbiased Equity Research and Insightful Analysis of the health and life science industry for the institutional and investment communities. Scimitar integrates scientific and financial analysis to identify those companies demonstrating real progress towards ...
Related newspaper, magazine, and journal articles:
|
|
Article: Scimitar Equity Research Issues Review of ...
PR Newswire;
September 9, 2005 ;
591 words
... ... 9 /PRNewswire/ -- Scimitar Equity Research, Inc. issues a review ... scimitarequity.com/. Scimitar Equity Research, Inc. (Scimitar) provides ... disclosures. CONTACT: Scimitar Equity Research, Inc. Henry W. McCusker ...
|
|